These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 3515949)
21. Cephalosporin therapy in intra-abdominal infection: comparative studies of cefotetan, latamoxef and cefoxitin. Wilson SE Chemioterapia; 1988 Aug; 7(4):213-7. PubMed ID: 3180298 [TBL] [Abstract][Full Text] [Related]
22. Comparison of cefotetan and cefoxitin prophylaxis for abdominal and vaginal hysterectomy. Berkeley AS; Freedman KS; Ledger WJ; Orr JW; Benigno BB; Gordon SF; McGregor JA; Galask RP; Sevin BU Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):706-9. PubMed ID: 3128112 [TBL] [Abstract][Full Text] [Related]
23. [Clinical study of cefotetan in obstetrics and gynecology]. Obata I; Imagawa N; Ochiai K; Koike K; Hachiya S Jpn J Antibiot; 1983 Sep; 36(9):2461-73. PubMed ID: 6581343 [TBL] [Abstract][Full Text] [Related]
24. [Evaluation of cefotetan in obstetrics and gynecology]. Yasuda J; Yamamoto T; Itoh M; Honjo H; Okada H; Kanao M Jpn J Antibiot; 1983 Sep; 36(9):2455-60. PubMed ID: 6581342 [TBL] [Abstract][Full Text] [Related]
25. Results of noncomparative studies of cefotetan in the treatment of obstetric and gynecologic infections. Poindexter AN; Ritter M; Faro S; Castellano MA; Gentry LO; Ismail M; Knuppel RA; Kreutner AK; Lamb EJ; LeFrock JL Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):717-21. PubMed ID: 3162652 [TBL] [Abstract][Full Text] [Related]
26. Cefoxitin in treatment of obstetric and gynecologic infections. Sweet RL; Robbie M; Hadley K Rev Infect Dis; 1979; 1(1):202-5. PubMed ID: 318223 [TBL] [Abstract][Full Text] [Related]
27. Single-dose cefotetan versus multiple-dose cefoxitin as prophylaxis in colorectal surgery. Jagelman DG; Fabian TC; Nichols RL; Stone HH; Wilson SE; Zellner SR Am J Surg; 1988 May; 155(5A):71-6. PubMed ID: 3287972 [TBL] [Abstract][Full Text] [Related]
28. [Clinical effect of cefotetan against infectious diseases in obstetrics and gynaecology]. Chimura T; Morisaki N; Goto T; Inoue K; Funayama T Jpn J Antibiot; 1983 Sep; 36(9):2450-4. PubMed ID: 6581341 [TBL] [Abstract][Full Text] [Related]
29. A comparative study of cefotetan versus cefoxitin plus metronidazole in the treatment of gynecological infections. Schwiersch U; Lang N Chemioterapia; 1987 Jun; 6(2 Suppl):541-2. PubMed ID: 3334618 [No Abstract] [Full Text] [Related]
30. Comparative effectiveness and safety of cefotetan and cefoxitin as prophylactic agents in patients undergoing abdominal or vaginal hysterectomy. Berkeley AS; Orr JW; Cavanagh D; Freedman KS; Ledger WJ; Pastorek JG; Sevin BU Am J Surg; 1988 May; 155(5A):81-5. PubMed ID: 3287974 [TBL] [Abstract][Full Text] [Related]
31. Results of a single-center study of cefotetan prophylaxis in abdominal or vaginal hysterectomy. Gordon SF Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):710-4. PubMed ID: 3128113 [TBL] [Abstract][Full Text] [Related]
32. Cefotetan (Cefotan): a new cephalosporin. Ahmed ME; May G; Branch RA Ration Drug Ther; 1986 Dec; 20(12):1-5. PubMed ID: 3303125 [No Abstract] [Full Text] [Related]
33. Cefotetan disodium (Cefotan). Med Lett Drugs Ther; 1986 Jul; 28(718):70-2. PubMed ID: 3523182 [No Abstract] [Full Text] [Related]
34. The use of intravenous cefoxitin sodium in patients with obstetric/gynaecologic infections. White JS; Gee C; Ledger WJ J Antimicrob Chemother; 1978 Jul; 4(B):239-40. PubMed ID: 357395 [No Abstract] [Full Text] [Related]
35. Moxalactam therapy for obstetric and gynecologic infections. Gall SA; Addison WA; Hill GB Rev Infect Dis; 1982; 4 Suppl():S701-7. PubMed ID: 6218587 [TBL] [Abstract][Full Text] [Related]